Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial - Gianni, L; Pienkowski, T; Im, Y H (Lancet Oncology, 2012)
et al.